Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BUFFALO, NY--(Marketwired - Feb 11, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the issuance of several new patents for entolimod in the U.S. and other countries, further...
-
BUFFALO, NY--(Marketwired - Feb 10, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will hold its 2015 Annual Meeting of Stockholders on April 14, 2015 in Buffalo, NY...
-
BUFFALO, NY--(Marketwired - Feb 5, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2015 BIO CEO & Investor Conference, February...
-
BUFFALO, NY--(Marketwired - Feb 4, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into definitive agreements with two institutional investors to purchase a...
-
BUFFALO, NY--(Marketwired - Jan 29, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced updates on oncology clinical development of entolimod (previously known as CBLB502). ...
-
BUFFALO, NY--(Marketwired - Jan 28, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Elena Kasimova of BioProcess Capital Partners to the Company's Board of...
-
BUFFALO, NY--(Marketwired - Jan 27, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that at a special meeting of stockholders held on January 27, 2015, stockholders authorized the...
-
BUFFALO, NY--(Marketwired - Jan 12, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company received notice that the proposal application to support further development of...
-
BUFFALO, NY--(Marketwired - Jan 6, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced updates on...
-
BUFFALO, NY--(Marketwired - Nov 13, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Roswell Park Cancer Institute (RPCI) today announced the publication of studies in Oncotarget describing the...